A once-daily formulation of tramadol (Tramadol ER) has been approved by the FDA for the treatment of moderate-to-moderately severe chronic pain.

Tramadol ER will be available in 100 mg, 200 mg, and 300 mg dosage strengths.

Tramadol ER is a product of Biovail, which plans to launch the medication commercially in early 2006.